Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development
Financial Post · · g2886242
Two strong partners aim to accelerate AI-enabled clinical development Building a foundation for Digital Patient Twins to bring safe and effective therapies to patients sooner Potential co-development of projects in Animal Health and business functions Cologne, Germany – Boehringer Ingelheim and Microsoft today announced a strategic collaboration that aims to bring safe and effective therapies […]
Cologne, Germany - Boehringer Ingelheim and Microsoft today announced a strategic collaboration that aims to bring safe and effective therapies to patients sooner fueled by AI. The collaboration will focus on jointly investigating the potential of Digital Patient Twins in clinical development. Digital Patient Twins are computational representations of individual patients that use clinical and other relevant data to predict how a disease might progress and how outcomes could evolve under different scenarios. Read More